Qualigen Therapeutics

Qualigen Therapeutics is a biotechnology company focused on developing and commercializing novel therapeutic products for cancer and infectious disease treatment, as well as expanding its flagship FastPack® diagnostic platform. Since 2002, the FDA-cleared and CE-marked FastPack® product line has been successfully utilized for diagnostics. The company’s therapeutic pipeline includes cancer drug compounds such as AS1411, AS1411-GNP, and RAS-F, as well as STARS (DNA/RNA-based therapeutic devices), aiming to provide exciting new treatment technologies for doctors and patients.